These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 35872339)
1. Targeting cyclin-dependent kinases 4/6 inhibits survival of megakaryoblasts in acute megakaryoblastic leukaemia. Qi K; Hu X; Yu X; Cheng H; Wang C; Wang S; Wang Y; Li Y; Cao J; Pan B; Wu Q; Qiao J; Zeng L; Li Z; Xu K; Fu C Leuk Res; 2022 Sep; 120():106920. PubMed ID: 35872339 [TBL] [Abstract][Full Text] [Related]
2. Fasudil promotes polyploidization of megakaryoblasts in an acute megakaryocyte leukemia model. He B; Wang C; Niu J; Wang F; Zhang Y; Gao Y; Yang Q Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):3101-3110. PubMed ID: 37162543 [TBL] [Abstract][Full Text] [Related]
3. [Blocking PAK1 kinase activity promotes the differentiation of acute megakaryocytic leukemia cells and induces their apoptosis]. Wang SJ; Wang CQ; Hu XT; Yu XR; Fu CL Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):499-505. PubMed ID: 35968594 [No Abstract] [Full Text] [Related]
4. Tetrandrine antagonizes acute megakaryoblastic leukaemia growth by forcing autophagy-mediated differentiation. Liu T; Zhang Z; Yu C; Zeng C; Xu X; Wu G; Huang Z; Li W Br J Pharmacol; 2017 Dec; 174(23):4308-4328. PubMed ID: 28901537 [TBL] [Abstract][Full Text] [Related]
5. Megakaryoblastic leukemia: a study on novel role of clinically significant long non-coding RNA signatures in megakaryocyte development during treatment with phorbol ester. Dahariya S; Raghuwanshi S; Sangeeth A; Malleswarapu M; Kandi R; Gutti RK Cancer Immunol Immunother; 2021 Dec; 70(12):3477-3488. PubMed ID: 33890137 [TBL] [Abstract][Full Text] [Related]
6. Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL. Wen Q; Goldenson B; Silver SJ; Schenone M; Dancik V; Huang Z; Wang LZ; Lewis TA; An WF; Li X; Bray MA; Thiollier C; Diebold L; Gilles L; Vokes MS; Moore CB; Bliss-Moreau M; Verplank L; Tolliday NJ; Mishra R; Vemula S; Shi J; Wei L; Kapur R; Lopez CK; Gerby B; Ballerini P; Pflumio F; Gilliland DG; Goldberg L; Birger Y; Izraeli S; Gamis AS; Smith FO; Woods WG; Taub J; Scherer CA; Bradner JE; Goh BC; Mercher T; Carpenter AE; Gould RJ; Clemons PA; Carr SA; Root DE; Schreiber SL; Stern AM; Crispino JD Cell; 2012 Aug; 150(3):575-89. PubMed ID: 22863010 [TBL] [Abstract][Full Text] [Related]
7. BMP2K dysregulation promotes abnormal megakaryopoiesis in acute megakaryoblastic leukemia. Wang M; Zhang T; Zhang X; Jiang Z; Peng M; Huang Z Cell Biosci; 2020; 10():57. PubMed ID: 32322386 [TBL] [Abstract][Full Text] [Related]
8. JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model. Mercher T; Wernig G; Moore SA; Levine RL; Gu TL; Fröhling S; Cullen D; Polakiewicz RD; Bernard OA; Boggon TJ; Lee BH; Gilliland DG Blood; 2006 Oct; 108(8):2770-9. PubMed ID: 16804112 [TBL] [Abstract][Full Text] [Related]
10. Molecular pathways: induction of polyploidy as a novel differentiation therapy for leukemia. Krause DS; Crispino JD Clin Cancer Res; 2013 Nov; 19(22):6084-8. PubMed ID: 23963861 [TBL] [Abstract][Full Text] [Related]
11. Target cell of leukemic transformation in acute megakaryoblastic leukemia. Koike T; Urushiyama M; Narita M; Saitoh H; Ishida F; Imashuku S; Morioka Y; Utsumi J; Ishizuka T; Tsuruta T Am J Hematol; 1990 Aug; 34(4):252-8. PubMed ID: 2164321 [TBL] [Abstract][Full Text] [Related]
12. Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS). Pelleri MC; Piovesan A; Caracausi M; Berardi AC; Vitale L; Strippoli P BMC Med Genomics; 2014 Dec; 7():63. PubMed ID: 25476127 [TBL] [Abstract][Full Text] [Related]
13. Effects of metformin on proliferation and apoptosis of human megakaryoblastic Dami and MEG-01 cells. Liang X; Kong P; Wang J; Xu Y; Gao C; Guo G J Pharmacol Sci; 2017 Sep; 135(1):14-21. PubMed ID: 28927780 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of cyclin D1 in the Dami megakaryocytic cell line causes growth arrest. Wilhide CC; Van Dang C; Dipersio J; Kenedy AA; Bray PF Blood; 1995 Jul; 86(1):294-304. PubMed ID: 7795236 [TBL] [Abstract][Full Text] [Related]
15. Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes. de Rooij JD; Branstetter C; Ma J; Li Y; Walsh MP; Cheng J; Obulkasim A; Dang J; Easton J; Verboon LJ; Mulder HL; Zimmermann M; Koss C; Gupta P; Edmonson M; Rusch M; Lim JY; Reinhardt K; Pigazzi M; Song G; Yeoh AE; Shih LY; Liang DC; Halene S; Krause DS; Zhang J; Downing JR; Locatelli F; Reinhardt D; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M; Gruber TA Nat Genet; 2017 Mar; 49(3):451-456. PubMed ID: 28112737 [TBL] [Abstract][Full Text] [Related]
16. A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy. Xavier AC; Edwards H; Dombkowski AA; Balci TB; Berman JN; Dellaire G; Xie C; Buck SA; Matherly LH; Ge Y; Taub JW PLoS One; 2011; 6(11):e27486. PubMed ID: 22110660 [TBL] [Abstract][Full Text] [Related]
17. Ultrastructural and ultracytochemical differences between megakaryoblastic leukemia in children and adults. Analysis of 49 patients. Eguchi M; Ozawa T; Sakakibara H; Sugita K; Iwama Y; Furukawa T Cancer; 1992 Jul; 70(2):451-8. PubMed ID: 1319816 [TBL] [Abstract][Full Text] [Related]
18. [Megakaryocytic leukemia cell lines and megakaryocytic leukemia]. Ryo R; Yoshida A; Yamaguchi N Rinsho Byori; 1990 May; 38(5):514-23. PubMed ID: 2381077 [TBL] [Abstract][Full Text] [Related]
19. Baicalein antagonizes acute megakaryoblastic leukemia in vitro and in vivo by inducing cell cycle arrest. Yu C; Zeng J; Yan Z; Ma Z; Liu S; Huang Z Cell Biosci; 2016; 6():20. PubMed ID: 27042290 [TBL] [Abstract][Full Text] [Related]